http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005074605-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee0c889922f5c338b9487ed1c3379190
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bba710e7aaa56d8ab15a910fcd3dc5f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-99003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y103-01024
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-06
filingDate 2005-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_438a8a76a517a79d97e97c15b019b2f8
publicationDate 2006-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005074605-A3
titleOfInvention Recombinant molecular products for expression of heme oxygenase-1, heme oxygenase-2, and/or biliverdin reductase for treatment of neurodegenerative diseases or disorders
abstract Methods of treating or preventing a neurodegenerative disease or disorder using ex vivo or in vivo gene therapy are disclosed. The gene therapy utilizes a chimeric gene or expression vector containing the same, where the chimeric gene includes a DNA molecule encoding a mammalian protein selected from the group of HO-1, HO-2, and BVR, and a promoter, expressible in neuronal cells that is operably coupled 5' of the DNA molecule. An additional method of treating or preventing a neurodegenerative disease or disorder involves administering to a patient a protein or polypeptide selected from HO-1, HO-2, and BVR.
priorityDate 2004-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6793926-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03055981-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003050273-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227014897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280353

Total number of triples: 26.